Drugmaker Novo Nordisk freezes hiring for non-critical jobs
Summary by Reuters
16 Articles
16 Articles
Danish pharmaceutical company Novo Nordisk has announced a global hiring freeze. The maker of the well-known diabetes and weight-loss drugs Ozempic and Wegovy recently appointed a new CEO, Maziar Mike Doustdar. He is trying to reduce costs amid increased competition in the market.
·Amsterdam, Netherlands
Read Full ArticleThe Danish pharmaceutical giant Novo Nordisk, which is behind the drug Ozempic, is preparing for a global hiring freeze, several Danish media outlets report. The freeze concerns services that are not considered essential for the company's continued operations, something that is confirmed by the press department of the newspaper Berlingske. The company's new CEO Mike Doustdar announced...
·Stockholm, Sweden
Read Full ArticleCoverage Details
Total News Sources16
Leaning Left2Leaning Right4Center4Last UpdatedBias Distribution40% Center, 40% Right
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
40% Right
L 20%
C 40%
R 40%
Factuality
To view factuality data please Upgrade to Premium